Morning Buzz: Pacira Pharmaceuticals (PCRX), LipoScience Inc (LPDX), Aixtron SE (AIXG)

Pacira Pharmaceuticals, Inc. (PCRX) announced that it has received a Warning Letter from the U.S. Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) referencing certain promotional materials on EXPAREL® (bupivacaine liposome injectable suspension). “We take regulatory compliance very seriously and believe that our current labeling supports the claims being challenged by the FDA,” […] View the full post at: Morning Buzz: Pacira Pharmaceuticals (PCRX), LipoScience Inc (LPDX), Aixtron SE (AIXG) No related posts.